Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.
about
MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cellsContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosisRole of inflammation in the pathogenesis of arterial stiffnessHIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis.Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cellsAssociations between the duration of dialysis, endotoxemia, monocyte chemoattractant protein-1, and the effects of a short-dwell exchange in patients requiring continuous ambulatory peritoneal dialysis.Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3.Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism.The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Contribution of calcium-activated chloride channel to elevated pulmonary artery pressure in pulmonary arterial hypertension induced by high pulmonary blood flow.Role of monocytes in atherogenesis.Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1α and macrophage inflammatory protein-2-dependent pathwayType 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation.Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty modelSmall RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cellsMonocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB ActivityAltered adipocyte progenitor population and adipose-related gene profile in adipose tissue by long-term high-fat diet in mice.The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model.Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1.Pathophysiology of vascular remodeling in hypertensionEffect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.Association of inflammatory gene polymorphisms and conventional risk factors with arterial stiffness by age.Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritisChlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1.Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages.Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
P2860
Q21135461-F95E5EA4-4286-41BE-BDF8-47D2499E9BD1Q28219354-FBFAF63A-B414-4A82-A2E2-A4A227AB4FD7Q28573076-3C7837FB-8D84-4818-BD66-43A41919BA20Q30318502-14E5F8D9-DBF8-4D0C-9BF9-99BA281E5890Q30319434-F513FF44-2D24-428B-8461-4F47984ABC4BQ30433361-D4F56AC9-F66F-4C13-908E-178B5D696755Q33352994-B377E51D-3832-4CEE-9D14-64D7C877DFEEQ33476859-3608A522-082F-44CE-A78A-3451355572E0Q34074859-AD99FE18-2E65-427D-BE3F-7163C082F289Q34294329-C3D7143C-1D9C-4568-B81B-B876DE6DACEEQ35047383-FF6A6E21-B8C4-4B08-AF37-3734943EA4CCQ35098401-89EAC6C7-C31E-4D34-901A-F9E4E04EC836Q35101448-61DD9038-DA4B-4F67-A5A2-38F243ABFE05Q35115789-E454F81A-EDC2-461E-AA48-321ABF430681Q35144883-2463B36A-C5B4-42D7-84D5-807324BF3597Q35541858-F15CCC50-B997-476E-B22C-8EBC3D1B9D6DQ35552775-E51267A5-A21E-40C6-AAD8-DE90336B7093Q35688313-4D69A372-5826-4922-9887-5E7331EAE0E2Q35848809-5519B04F-B330-4198-9F38-2927E40E52ADQ35939806-B9E29777-4894-4388-A241-8E19C7294683Q35994680-BB5A0ACF-947F-4A02-99D9-4C0B93329414Q36079859-CDFFE6FB-67D7-462F-AA1E-E63E8E0B7A7FQ36237879-DD2584C7-C6DB-4E31-8F81-57CC7D3206A1Q36310750-9CD4D530-B3E2-4597-A2CF-E5964E215EE8Q36404955-6CB4EE9D-AF9C-4263-8D7A-91CF8653E98AQ36608863-BE8D5B05-4FA7-4BDA-89ED-6C345ED0590CQ36764263-715C25E5-4BA5-4341-98EA-0827D715A148Q37057306-2E578CA1-C1C0-4941-91B7-5644253EB5ABQ37077772-36BA1336-A238-4562-B582-CEFC16B8F97BQ37317440-8517AACE-7170-4B42-8F7F-D21E176623D6Q37326035-94934500-D649-4C3E-8017-4BDE70A6822BQ37433269-46020F1E-1F2F-4237-B0CB-E73E5C2B7239Q37853901-CDF138D0-1AA6-4458-BE6D-1DA4B4514431Q37861765-AA7C5EF7-1FDF-40B3-96F8-924EA049D6DFQ38103313-80FEB7C9-584B-4A58-87CD-E8C6187AAC77Q38298806-BF81D3B4-8785-41D9-A3FB-111055446268Q38698722-1669D085-648F-4146-B642-9E574836206CQ38960576-C285F307-3311-428C-B596-FDF67C7E23F6Q39354315-24C2EB44-4726-466F-8CF0-72858F61EABDQ41308457-32F823B0-6A23-4BAB-9F7B-C3B0CD5E30A2
P2860
Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@en
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@nl
type
label
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@en
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@nl
prefLabel
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@en
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@nl
P2093
P1476
Monocyte chemoattractant prote ...... appaB and activator protein-1.
@en
P2093
Christiane Viedt
Judith Vogel
Jörg Kreuzer
Stephan R Orth
Thomas Athanasiou
Weili Shen
Wolfgang Kübler
P304
P356
10.1161/01.ATV.0000019009.73586.7F
P407
P577
2002-06-01T00:00:00Z